| Financial Year |
March 31 2023 |
| Monetary Funds |
1,771,722,232.77 |
| Held-for-trading Financial Assets |
2,545,156,139.50 |
| Notes Receivable |
2,608,374.49 |
| Accounts Receivable |
18,915,455.67 |
| Advances to Suppliers |
30,274,704.46 |
| Other Receivables |
15,273,443.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
646,810,277.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
822,394,871.87 |
| Other Current Assets |
160,315,091.48 |
| Total Current Assets |
6,013,470,590.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
544,647,324.23 |
| Investment Properties |
-- |
| Fixed Assetes |
3,730,689,875.38 |
| Under-construction Projects |
48,952,740.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
745,493,796.18 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
401,529,461.80 |
| Deferred Income Tax Assets |
82,133,191.66 |
| Other Non-Current Assets |
90,520,401.52 |
| Sub-Total of Non-Current Assets |
7,025,565,321.24 |
| Total Assets |
13,039,035,912.08 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
690,217,437.25 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
26,305,383.79 |
| Taxes Payable |
108,622,959.69 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
121,645,109.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
20,550,410.16 |
| Sub-Total of Current Liabilities |
1,130,790,202.56 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
54,885,163.32 |
| Deferred Income Tax Liabilities |
213,346,386.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
301,330,156.02 |
| Total Liabilities |
1,432,120,358.58 |
| Paid-In Capital(Or Share Stock) |
1,192,275,016.00 |
| Capital Surplus |
3,765,781,204.54 |
| Surplus Reserve |
657,678,159.94 |
| LESS:Treasury Stock |
207,278,402.67 |
| Undistributed Profits |
6,057,663,059.91 |
| Minority Stockholder's Interest |
35,811,401.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,571,104,151.75 |
| Owner's Equity（Stockholder's Equity） |
11,606,915,553.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,039,035,912.08 |
